Patent · US Active

Antibodies and methods for treating estrogen receptor-associated diseases

US10233249B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

BEIJING SHENOGEN PHARMA GROUP LTD. · CN

Inventors

Xueming Qian · Thousand Oaks, US
Kun Meng · Beijing, CN
Feng-Jing Chen · New York, US
Xiao Shang · Bellevue, US
Jing Wang · Milford, US
Lu Li · Camarillo, US
Congya Zhou · Beijing, CN

Key dates

Filing date	Mar 19, 2014
Grant date	Mar 19, 2019
Priority date	—
Expiry date	Jul 20, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/723
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein in certain embodiments are antibodies, antibody fragments, pharmaceutical compositions, methods for modulating the functions of estrogen receptor alpha 36, and methods for preventing and/or treating diseases mediated by estrogen receptor alpha 36.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.